Evidence map›Paper›PMID 23996193›Full record

ReviewHistochemistry and cell biology2013

Components of the CtBP1/BARS-dependent fission machinery.

Carmen Valente, Alberto Luini, Daniela Corda

Abstract readReview
PubMed Publisher
In one paragraph

Review in Histochemistry and cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Phosphatidic acid signaling and function in nuclei.Progress in lipid research · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Structure and regulation of human phospholipase D.Advances in biological regulation · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Protein Amphipathic Helix Insertion: A Mechanism to Induce Membrane Fission.Frontiers in cell and developmental biology · 2019
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Carmen ValenteInstitute of Protein Biochemistry, National Research Council, Via Pietro Castellino 111, 80131, Naples, Italy, c.valente@ibp.cnr.it.
Alberto Luini
Daniela Corda
Institute of Protein Biochemistry · ITNational Research Council · ITTelethon Institute Of Genetics And Medicine · IT

Funding

Telethon TGM11CB5
6 · The paper itself

Abstract

The brefeldin A ADP-ribosylated substrate, a member of the C-terminal-binding protein family that is referred to as CtBP1/BARS, is a dual-function protein that acts as a transcriptional co-repressor in the nucleus and as an inducer of membrane fission in the cytoplasm. In this review, we first discuss the mechanisms that enable CtBP1/BARS to shift between the nuclear transcriptional co-repressor and the cytosolic fission-inducing activities. Then, we focus on the role of CtBP1/BARS in membrane fission. CtBP1/BARS controls several fission events including macropinocytosis, fluid-phase endocytosis, COPI-coated vesicle formation, basolaterally directed post-Golgi carrier formation, and Golgi partitioning in mitosis. We report on recent advances in our understanding of the CtBP1/BARS membrane fission machineries that operate at the trans-side and at the cis-side of the Golgi complex. Specifically, we discuss how these machineries are assembled and regulated, and how they operate in the formation of the basolaterally directed post-Golgi carriers.

Indexed as

AnimalsCOP-Coated VesiclesDNA-Binding ProteinsEndocytosisHumansIntracellular MembranesProtein Processing, Post-Translationaltrans-Golgi NetworkDNA-Binding Proteins

Identifiers

PMID23996193
OpenAlexW2076616447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.